AWAK bags $20M in Series B funding
Despite a challenging market condition, Singapore-based medtech AWAK Technologies has raised more than $20 million in a Series B funding round – one of the biggest funding raises in Southeast Asia this year. The round was co-led by Lion X Ventures and Vickers Venture Partners.
AWAK is developing a portable peritoneal dialysis device that allows users to undergo...
Tel Aviv-based AI-enabled computational protein engineering platform Scala Biodesign announced its launch today with $5.5 million in seed funding.
The round was led by TLV Partners, an Israeli venture capital firm that invests in early-stage startups.
WHAT IT DOES
Scala's computational method utilizes AI, physics-based modeling and biological data analysis to engineer and improve proteins for...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for chronic obstructive pulmonary disease patients in the U.S.
COPD is a chronic inflammatory lung disease that obstructs airflow from the lungs and causes breathing problems. Tiotropium Bromide treats...
E-pharmacy MrMed scores half mil for expansion
Online pharmacy MrMed has raised $500,000 from a funding round led by the Tamil Nadu Emerging Sector Seed Fund.
According to a news report, the company will use its fresh funds to expand its team and reach out to more customers.
Launched in 2021, the pharmacy startup offers specialty medicines for cancer, heart disorders, and other critical health...
California-based AI drug discovery startup Genesis announced it scored a whopping $200 million in an oversubscribed Series B funding round, bringing its total raise to $280 million.
The company also announced that approximately $24 million of SAFE notes from a prior funding round were converted amid the closing of the Series B round.
Andreessen Horowitz and a "U.S.-based life sciences-focused...
Global clinical technology company Wolters Kluwer Health and health tech company Unbound Medicine announced the launch of a mobile app version of Lippincott’s Nursing Drug Handbook, a pocket drug guide for nurses.
The app, which brings the print edition of Lippincott's handbook to the digital space, will include latest updates from the FDA and data on more than 3,800 generic, brand name and...
Causaly, a tech company using AI to interpret large datasets and literature, announced it closed a $60 million Series B round led by ICONIQ Growth.
Marathon Venture Capital, Index Ventures, Pentech Ventures, EBRD and Visionaries Club also participated in the round, as did former chairman and CEO of Johnson & Johnson Alex Gorsky and CEO and cofounder of Datadog Olivier Pomel.
WHAT IT DOES...
CVS Caremark, a pharmacy benefit manager and part of CVS Health, announced it is partnering with drug cost and telehealth company GoodRx to launch Caremark Cost Saver, providing Caremark's members access to GoodRx's lower-cost prescription pricing.
Beginning January 1, 2024, Caremark's members can use their existing benefit card at an in-network pharmacy of their choice to automatically have...
Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone.
Posterity Health is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues...
Mark Cuban Cost Plus Drug Company (MCCPDC) announced that it's working with Coherus Biosciences to sell Yusimry, a biosimilar version of the top-selling drug Humira, at a discounted price.
Yusimry is used to treat several diseases, such as rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ulcerative colitis, hidradenitis suppurativa, Crohn’s...
_164d6.jpg "Mark Cuban, cofounder of Mark Cuban Cost Plus Drug Company")
